Type 2 Diabetes

Study results confirm the validity of the Seattle Angina Questionnaire section focusing on chronic angina frequency, showing it correlated strongly with patients' daily diary entries regarding angina frequency and medication use.

Presentation at the 2013 Southern Hospital Medicine Conference reviewed the clinical application of several key risk indices, including the Revised Cardiac Risk Index and the Vascular Study Group of New England Risk Index.

Endocrinologist Pavan Chava, DO, discusses available methods to prolong glycemic control in hospitalized diabetics while avoiding hyperglycemia and hypoglycemia.

Oxytocin has great potential to become a next-generation peptidyl drug target for obesity and diabetes.

New evidence suggests that physical activity and drug interventions are similar in terms of mortality benefits in the secondary prevention of congestive heart failure (CHF), rehabilitation after stroke, treatment of heart failure, and prevention of diabetes.

The intensive lifestyle intervention used in type 2 diabetes patients in the Look AHEAD trial was deemed futile over time.

A recent statistical analysis on postmenopausal women has evaluated the association between self-reported daily sitting time and the incidence of type 2 diabetes.

This resource describes several measures that patients with diabetes can take to prevent or control diabetic neuropathy, including peripheral neuropathy.

Study results indicate that diabetes mellitus is independently associated with the development of cirrhosis and hepatocellular carcinoma among patients who have fatty liver disease.

A team of German researchers has identified differences in metabolic health patterns across an obese population.

Although pen devices are perceived to be more costly than vialed insulin, new study results indicate that elderly diabetic patients are more likely to accept pen devices and adhere to therapy, which decreases long-term complications and associated healthcare costs.

Group visits can be an especially effective tool for providing follow-up care to patients with chronic conditions, offering them increased access to clinicians and other providers, support and encouragement from their peers, and enhanced educational opportunities.

Early diagnosis by primary care physicians and aggressive treatment are essential to slowing the epidemic of kidney and cardiovascular disease.

In one study, 49% of participants with diabetes had osteoarthritis compared with 26% of participants without diabetes.

Following the American Medical Association's formal recognition of obesity as a disease, Boston University researchers attempted to identify better ways to determine health status in obese patients.

Researchers have studied the effects of hormone therapy on the lipid profiles of postmenopausal women.

The lifestyle medicine discipline offers the potential to strengthen patients' capacities to make healthier choices and foster good health.

Using nutritional supplement mixtures consisting of arginine, glutamine, and beta-hydroxy-beta-methylbutyrate (HMB) may speed up wound healing in diabetic foot ulcers.

Researchers have published their findings from the NIH-sponsored Look AHEAD clinical trial in three areas relevant to type 2 diabetes management.

Patients who are unaware that they have diabetes may have less contact with healthcare professionals, receive less aggressive treatment, or have a poorer understanding of the disease and the actions required to treat it - all of which may be responsible for their increased risk of morbidity and mortality.

In clinical testing, the MD-Logic Artificial Pancreas system significantly improved overnight glucose control and decreased the duration of hypoglycemia in type 1 diabetes patients.

While substantial evidence already shows several genetic and environmental elements factor into immune-mediated rheumatic disease susceptibility, a recent review of hospital admissions data suggests vitamin D deficiency can single-handedly elevate a patient's risk of developing certain chronic conditions within that group of disorders.

A pair of researchers based in Texas has gained valuable insight into the correlation between individual cell type in the tissues of gout patients and comorbidity factors of the chronic inflammatory autoimmune disorder.

By adopting a comprehensive set of case management policies for the care of diabetic and hyperglycemic patients, Johns Hopkins Hospital improved in-hospital mortality rate, reduced length of stay, and reduced hyperglycemia.

Exposure to insulin glargine and metformin did not cause increased risk of cancer or worse cancer outcomes.

Results of a three-year trial of the experimental GLP-1 receptor agonist albiglutide showed that it had a better effect on HbA1c, fasting blood glucose, and body weight than two comparator drugs.

Prescription-strength doses of vitamin D improve highly prevalent comorbidities among diabetic women, such as depression and pain, and also improve risk factors such as excess weight and high blood pressure.

While the current ADA guidelines recommend targeting HbA1c levels to below 8% for high-risk patients with diabetes, reducing the level to 5.7% dose not raise CVD or overall mortality risk, according to a recent study.

A novel algorithm for patient self-adjustment of prandial insulin dose could make it easier for patients who are poorly-controlled on basal insulin to add meal-time insulin.